Cargando…
Immune Thrombocytopenia (ITP): Relapse Versus de novo After COVID-19 Vaccination
Autores principales: | Al-Ahmad, Mona, Al Rasheed, Mona, Shalaby, Neveen, Rodriguez-Bouza, Tito, Altourah, Lulwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814962/ https://www.ncbi.nlm.nih.gov/pubmed/35108113 http://dx.doi.org/10.1177/10760296211073920 |
Ejemplares similares
-
Isolated thrombosis after COVID-19 vaccination: case series
por: Al-Ahmad, Mona, et al.
Publicado: (2022) -
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca‐Oxford COVID‐19 vaccine
por: Al‐Ahmad, Mona, et al.
Publicado: (2021) -
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022) -
Response to rituximab in children and adults with immune thrombocytopenia (ITP)
por: Harris, Emily M., et al.
Publicado: (2021) -
Severe Immune Thrombocytopenia (ITP) Following SARS-CoV-2 mRNA Vaccine in a Girl on Immunosuppressive Treatment and in Prolonged Stable Phase of ITP
por: Bianchi, Simona, et al.
Publicado: (2022)